Extended prophylaxis with semuloparin reduces VTE after hip fracture surgery
Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery - the SAVE-HIP3 studyBone Joint J. 2013 Apr 1;95-B(4):459-66. doi: 10.1302/0301-620X.95B4.30730
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Dr. Fisher discusses extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery
Following a 7-10 day open label run-in phase which studied the safety and efficacy of prophylaxis with semuloparin, 469 patients were randomized in a 2:1 ratio to a 19-23-day long treatment of either semuloparin or a placebo in a double blind phase. 23 days after the end of treatment, the semuloparin group had a 79% relative risk reduction in the rate of any venous thromboembolism or all-cause dea...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue